Literature DB >> 14551480

Influenza A community-acquired pneumonia in East London infants and young children.

Matthew Laundy1, Ekundayo Ajayi-Obe, Khidir Hawrami, Celia Aitken, Judith Breuer, Robert Booy.   

Abstract

BACKGROUND: Community-acquired pneumonia (CAP) is common in young children, but there are few data in Europe on influenza A virus as a cause of childhood CAP. The aim of this study was to determine the relative contributions of different etiologic agents to CAP in children.
METHODS: This was a 6-month prospective study of pediatric accident and emergency and general practice consultations with a diagnosis of CAP. Nasopharyngeal aspirates for viral immunofluorescence and PCR studies and blood cultures for bacterial studies were taken from 51 children with symptoms, signs and chest radiographic features that satisfied a diagnosis of pneumonia.
RESULTS: An etiologic agent was isolated from 25 patients (49%). A viral cause was identified in 22 patients (43%), and influenza A virus and respiratory syncytial virus (RSV) were detected in 16 and 18% of all cases, respectively. Only four patients (8%) had a positive bacterial blood culture; three had Streptococcus pneumoniae and one had Neisseria meningitidis W135. Mycoplasma pneumoniae was detected in 2 children, and mixed infections were detected in 5 (10%). The use of viral PCR increased the detection rate of influenza A virus by 100%.
CONCLUSION: Influenza A virus caused more than one-third of all viral CAP cases, a rate comparable with that of RSV CAP. Viral PCR doubled the diagnostic yield of influenza A virus. The clinical burden of influenza A CAP was comparable with that of RSV CAP, as measured by the duration of fever, hospital stay and total duration of illness.

Entities:  

Mesh:

Year:  2003        PMID: 14551480     DOI: 10.1097/01.inf.0000092192.59459.8b

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts.

Authors:  Terho Heikkinen; Robert Booy; Magda Campins; Adam Finn; Per Olcén; Heikki Peltola; Carlos Rodrigo; Heinz-Josef Schmitt; Fabian Schumacher; Stephen Teo; Catherine Weil-Olivier
Journal:  Eur J Pediatr       Date:  2005-12-21       Impact factor: 3.183

Review 2.  Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis.

Authors:  Christian Marchello; Ariella Perry Dale; Thuy Nhu Thai; Duk Soo Han; Mark H Ebell
Journal:  Ann Fam Med       Date:  2016-11       Impact factor: 5.166

Review 3.  Influenza burden of illness, diagnosis, treatment, and prevention: what is the evidence in children and where are the gaps?

Authors:  S S S Teo; J S Nguyen-Van-Tam; R Booy
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791

4.  Assessing the potential of upper respiratory tract point-of-care testing: a systematic review of the prognostic significance of upper respiratory tract microbes.

Authors:  H V Thornton; K M E Turner; S Harrison; A Hammond; C Hawcroft; A D Hay
Journal:  Clin Microbiol Infect       Date:  2019-06-26       Impact factor: 8.067

5.  Incidence of viral infection detected by PCR and real-time PCR in childhood community-acquired pneumonia: a meta-analysis.

Authors:  Min Wang; Feng Cai; Xiaodong Wu; Ting Wu; Xin Su; Yi Shi
Journal:  Respirology       Date:  2015-01-23       Impact factor: 6.424

6.  The burden of pneumonia in children: an Australian perspective.

Authors:  David Burgner; Peter Richmond
Journal:  Paediatr Respir Rev       Date:  2005-06       Impact factor: 2.726

7.  Mixed community-acquired lower respiratory tract infections.

Authors:  Paolo Tarsia; Stefano Aliberti; Maria Pappalettera; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

8.  Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine.

Authors:  Mohamed A Elemraid; Andrew D Sails; Gary J A Eltringham; John D Perry; Stephen P Rushton; David A Spencer; Matthew F Thomas; Katherine M Eastham; Fiona Hampton; Andrew R Gennery; Julia E Clark
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.